[Hisco: Net profit is expected to increase by 297%-321% year-on-year in the first three quarters] On October 20, HiSco (002653.SZ) announced that the net profit attributable to shareholders of listed companies in the first three quarters of 2026 is expected to be 1.320 billion yuan-1.400 billion, a year-on-year increase of 297.02%-321.08%. The change in performance is mainly due to the continued rapid growth in domestic sales of the company's innovative drugs, as well as the signing of multiple product licensing transaction contracts to receive down payments and other payments, and the realization of a large amount of product licensing income. Xiaocai Note: The company’s Q3 net profit is expected to be 469 million-549 million, and Q2 net profit is 297 million. Based on this calculation, Q3 net profit is expected to increase by 58%-85% month-on-month.